ImmunityBio, Inc. earnings per share and revenue

IBRX earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.16 USD which accounts for -25.00% surprise. Company revenue for the same period amounts to 1.05 M USD despite the estimated figure of 14.71 M USD. Estimated earnings per share for the next quarter are -0.18 USD, and revenue is expected to reach 2.92 M USD. Also watch annual changes over time to get a bigger picture of IBRX earnings per share and revenue dynamics.